Talecris Biotherapeutics
Clinical Studies
Print This Page E-mail This Page
Talecris Clinical Studies
Clinical Study Results

Clinical Studies Site Map

Use this site map to navigate the Clinical Studies site.

  • Talecris Clinical Studies
    •   Alpha-1-Antitrypsin (AAT) To Treat Emphysema In AAT-Deficient Patients
     
      Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis (PRIVIG)
     
      Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (ICE Study)
     
      Deposition of Inhaled Prolastin in Cystic Fibrosis Patients (CF2)
     
      Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration
     
      Rapid Infusion of Immune Globulin Intravenous (IGIV) In Patients With ITP
     
      Tetanus Immunization In Subjects With No Immunization History or With Tetanus Antibody Levels Below Protective Levels
     

     

     
    Talecris Biotherapeutics
    Site Map    General Conditions of Use    Privacy Statement   
    Copyright © 2005-2012 Grifols Therapeutics Inc., a subsidiary of Grifols Inc. All rights reserved.